June 15, 2020 / 4:39 PM / 20 days ago

BRIEF-Janssen Announced New Long-Term Plaque Psoriasis Data For Tremfya

June 15 (Reuters) - JANSSEN:

* JANSSEN - ANNOUNCED NEW LONG-TERM PLAQUE PSORIASIS DATA FOR TREMFYA

* JANSSEN - NEW PHASE 3 DATA FOR TREMFYA SHOW CONSISTENT, HIGH LEVELS OF SKIN CLEARANCE THROUGH 4 YRS IN ADULTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

* JANSSEN - SAFETY PROFILES OBSERVED FOR GUSELKUMAB AND ADALIMUMAB IN VOYAGE 2 WERE CONSISTENT WITH KNOWN SAFETY PROFILES

* JANSSEN - DATA SHOWS HIGHER PROPORTION OF PATIENTS TREATED WITH GUSELKUMAB REPORTED SYMPTOM-FREE & SIGN-FREE STATUS THROUGH 48 WEEKS VERSUS ADALIMUMAB

* JANSSEN - NO NEW SAFETY SIGNALS WERE IDENTIFIED AT FOUR YEARS IN PRESENTED ANALYSES OF TREMFYA Source text: (bit.ly/3hxSVna) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below